semaglutide mdv Flex-Dose 2 mL Injectable 2.5 mg/mL Higher-Dose Semaglutide Injection Proves Mettle

In this week's Wellness Briefing, West Coast correspondent Lexy Lebsack checked in with Alyssa Williams Atkinson, category insights manager at SPATE market research, to unpack the stunning online growth of the wellness patches marketplace

Oral semaglutide (Rybelsus) is the only tablet form currently available

A rising number of individuals have reported serious side effects, with the most severe cases leading to permanent consequences

Many companies aside from Lilly and Novo Nordisk are also jumping on the train, testing their own GLP-1s in clinical trials, which could help with shortages in the future

Supports Weight Loss*